HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rhaponticin from rhubarb rhizomes alleviates liver steatosis and improves blood glucose and lipid profiles in KK/Ay diabetic mice.

Abstract
We isolated several stilbene compounds including rhaponticin (3',5-dihydroxy-4'-methoxystilbene 3- O-beta- D-glucopyranoside) from extracts of rhubarb rhizomes. These compounds showed significant hypoglycemic effects in streptozotocin (STZ)-induced type 1 diabetic rats and mice. In this study, we investigated the effect of rhaponticin on glucose utilization, lipid metabolism, and liver and heart function in a KK/Ay type 2 diabetic mouse model. The results showed that oral administration of rhaponticin (125 mg/kg) significantly reduced blood glucose levels and improved oral glucose tolerance of KK/Ay diabetic mice. Elevated plasma triglyceride (TG), low density lipoprotein (LDL), cholesterol (CHO), non-esterified free fatty acids (NEFA), and insulin levels were also markedly attenuated. Serum enzymatic activities of lactate dehydrogenase (LDH), creatine kinase (CK), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) in the rhaponticin-treated group significantly decreased in comparison to the untreated model group. Livers of rhaponticin-treated mice had relatively normal cellular size and decreased fibrosis and steatosis. In addition, rhaponticin administration caused a remarkable increase in the hepatic glycogen content and a significant reduction in the hepatic triglyceride content. These results indicate that rhaponticin has a noticeable antidiabetic effect and could be potentially used as a new agent to treat type 2 diabetes mellitus and its complications.
AuthorsJinlong Chen, Mengmeng Ma, Yanwei Lu, Lisheng Wang, Chutse Wu, Haifeng Duan
JournalPlanta medica (Planta Med) Vol. 75 Issue 5 Pg. 472-7 (Apr 2009) ISSN: 1439-0221 [Electronic] Germany
PMID19235684 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Enzymes
  • Fatty Acids, Nonesterified
  • Hypoglycemic Agents
  • Insulin
  • Lipids
  • Lipoproteins, LDL
  • Stilbenes
  • Triglycerides
  • Glycogen
  • Cholesterol
  • rhapontin
Topics
  • Animals
  • Blood Glucose (metabolism)
  • Cholesterol (blood)
  • Diabetes Mellitus, Experimental (drug therapy, metabolism)
  • Enzymes (blood)
  • Fatty Acids, Nonesterified (blood)
  • Fatty Liver (drug therapy, metabolism)
  • Glucose Tolerance Test
  • Glycogen (metabolism)
  • Hypoglycemic Agents (isolation & purification, pharmacology, therapeutic use)
  • Insulin (blood)
  • Lipids (blood)
  • Lipoproteins, LDL (blood)
  • Liver (drug effects, metabolism, pathology)
  • Mice
  • Rheum (chemistry)
  • Rhizome
  • Stilbenes (isolation & purification, pharmacology, therapeutic use)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: